NEW YORK (GenomeWeb News) – Becton Dickinson today reported that its first-quarter 2013 revenues increased 4 percent year over year as the firm beat Wall Street estimates on the top and bottom line.

BD reported total revenues of $1.90 billion for the three months ended Dec. 31, compared to $1.83 billion for the first quarter of 2012. Analysts, on average, had expected revenues of $1.86 billion. On a currency-neutral basis, BD's Q1 revenues were up 5 percent.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Researchers hope to tease out the signature effects that different carcinogens leave on the genome to determine their contributions to disease, Mosaic reports.

The Wall Street Journal looks into the cost of new gene therapies.

An Imperial College London-led team reports that it was able to use a gene drive to control a population of lab mosquitos.

In PNAS this week: genomic effects of silver fox domestication, limited effect of mitochondrial mutations on aging in fruit flies, and more.